A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease

Advances in Experimental Medicine and Biology

Volumn 457, Issue , 1999, Pages 71-75

  Rund, Deborah ^a   Azar, Idit ^a   Shperling, Olga ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 3;

ARTICLE; BLOOD; BLOOD DISEASE; GENE; GENETICS; HETEROZYGOTE DETECTION; HUMAN; LEUKEMIA; MULTIDRUG RESISTANCE; NONHODGKIN LYMPHOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; REFERENCE VALUE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; GENES, MDR; HEMATOLOGIC NEOPLASMS; HETEROZYGOTE DETECTION; HUMANS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; P-GLYCOPROTEIN; P-GLYCOPROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); REFERENCE VALUES;

EID: 0032620210     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4811-9_9     Document Type: Article

References (18)

1. Pastan I, Gottesman M: Multidrug resistance. Ann Rev Med 1991;42:277-286
2. Simon S, Schindler M: Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91:3497-3504, 1994
3. Jones P: DNA methylation errors and cancer. Cancer Research 1996;56:2463-2467
4. Stein U, Walther W, Wunderlich V: Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Euro J Cancer 1994;30A:1541-1545
5. Chaudhary P, Roninson I: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94
6. Broxterman H, Lankelman J, Pinedo H, Eekman C, Wahrer D, Ossenkoppele G, Schuurhuis G: Theoretical and practical considerations for the measurement of P-glycoprotein function in acute meyloid leukemia. Leukemia 1997;11:1110-1118
7. Webb M, Raphael C, Asbahr H, Erber W, Meyer B: The detection of rhodamine 123 drug efflux at low levels of drug resistance. Br J Haematol 1996;93:650-655
8. Young I: Proof without prejudice: use of Kolgomorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem Cytochem 1977;25:935-941
9. Beck W, Grogan T, Williams C, Cordon-Cardo C, Parham D, Kuttesch J, Andreef M, Bates S, Berard C, Boyett J, Brophy N, Broxterman H, Chan H, Dalton W, Dietel M, Fojo A, Gascoyne R, Head D, Houghton P, Srivastava D, Lehnert M, Leith C, Paietta E, Pavelic Z, Rimsza L, Roninson I, Sikie B, Twentyman P, Warnke R, Weinstein R: Methods to detect P-glycoprotein-associated resistance in patients' tumors: consensus recommendations. Cancer Research 1996;56:3010-3020
10. Ivy S, Olshevski R, Taylor B, Patel K, Reaman G: Correlation of P-glycoprotein expression and function in childhood acute leukemia,. Blood 1996;88:309-318
11. Pall G, Spitaler M, Gofman J, Thaler J, Ludescher C: Multidrug resistance in leukemia: a comparison of different diagnostic methods. Leukemia 1997:11:1067-1072
12. Rund D, Cohen T, Filon D, Dowling CE, Warren TC, Barak I, Rachmilewitz EA, Kazazian HH, Oppenheim A: Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci USA 1991;88:310-314
13. Hayashi K: PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Method Applications 1991:1:34-38
14. Glavac D, Dean M: Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Human Mutation 1993:2:404-414
15. Ueda K, Pastan I, Gottesman M: Isolation and sequence of the promoter region of the human multi-drug resistance (P-glycoprotein) gene. J Biol Chem 1987;262:17432-17436
16. Cornwell M, Smith D: SPI activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem 1993;26:19505-19511
17. Cohen D, Yu L, Rzepka R, Horwitz S: Identification of two nuclear protein binding sites and their role in the regulation of the murine multidrug resistance mdr1a promoter. DNA and Cell Biology 1994;13:641-649
18. van Groenigen M, Valentijn L, Baas F: Identification of a functional initiator sequence in the human MDR1 promoter. Biochimica Biophysica Acta 1993;1172:138-146